Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials

Taylor Bucy, John M. Zoscak, Motomi Mori, Uma Borate

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials'. Together they form a unique fingerprint.

Social Sciences

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science